Pregnancy Specific beta-1-Glycoprotein 5 (PSG5) Peptide
-
- Target See all PSG5 products
- PSG5 (Pregnancy Specific beta-1-Glycoprotein 5 (PSG5))
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PSG5 antibody (Catalog #: ARP42067_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PSG5 (Pregnancy Specific beta-1-Glycoprotein 5 (PSG5))
- Background
-
The pregnancy-specific beta 1 glycoprotein (PSG) is a group of heterogeneous proteins produced in large amounts by the human syncytiotrophoblast. They belong to the carcinoembryonic antigen (CEA) family. The function of PSG5 remains unknown.
Alias Symbols: FL-NCA-3, PSG
Protein Interaction Partner: PRPF40A
Protein Size: 335 - Molecular Weight
- 37 kDa
- Gene ID
- 5673
- NCBI Accession
- NM_002781, NP_002772
- UniProt
- Q15238
-